These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36764853)

  • 1. Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder.
    Holmes SE; Asch RH; Davis MT; DellaGioia N; Pashankar N; Gallezot JD; Nabulsi N; Matuskey D; Sanacora G; Carson RE; Blumberg HP; Esterlis I
    Biol Psychiatry; 2023 Jun; 93(12):1099-1107. PubMed ID: 36764853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficits in prefrontal metabotropic glutamate receptor 5 are associated with functional alterations during emotional processing in bipolar disorder.
    Asch RH; Worhunsky PD; Davis MT; Holmes SE; Cool R; Boster S; Carson RE; Blumberg HP; Esterlis I
    J Affect Disord; 2024 Sep; 361():415-424. PubMed ID: 38876317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary Study of White Matter Abnormalities and Associations With the Metabotropic Glutamate Receptor 5 to Distinguish Bipolar and Major Depressive Disorders.
    Fan S; Asch RH; Davis MT; DellaGioia N; Cool R; Blumberg HP; Esterlis I
    Chronic Stress (Thousand Oaks); 2024; 8():24705470231225320. PubMed ID: 38250007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic Glutamatergic Receptor 5 and Stress Disorders: Knowledge Gained From Receptor Imaging Studies.
    Esterlis I; Holmes SE; Sharma P; Krystal JH; DeLorenzo C
    Biol Psychiatry; 2018 Jul; 84(2):95-105. PubMed ID: 29100629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic Glutamate Receptor 5 and Glutamate Involvement in Major Depressive Disorder: A Multimodal Imaging Study.
    Abdallah CG; Hannestad J; Mason GF; Holmes SE; DellaGioia N; Sanacora G; Jiang L; Matuskey D; Satodiya R; Gasparini F; Lin X; Javitch J; Planeta B; Nabulsi N; Carson RE; Esterlis I
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Jul; 2(5):449-456. PubMed ID: 28993818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation.
    Davis MT; Hillmer A; Holmes SE; Pietrzak RH; DellaGioia N; Nabulsi N; Matuskey D; Angarita GA; Carson RE; Krystal JH; Esterlis I
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11490-11495. PubMed ID: 31085640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential neural correlates of autobiographical memory recall in bipolar and unipolar depression.
    Young KD; Bodurka J; Drevets WC
    Bipolar Disord; 2016 Nov; 18(7):571-582. PubMed ID: 27813234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.
    Deschwanden A; Karolewicz B; Feyissa AM; Treyer V; Ametamey SM; Johayem A; Burger C; Auberson YP; Sovago J; Stockmeier CA; Buck A; Hasler G
    Am J Psychiatry; 2011 Jul; 168(7):727-34. PubMed ID: 21498461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-Dependent Differences in Emotion Regulation Between Unmedicated Bipolar Disorder and Major Depressive Disorder.
    Rive MM; Mocking RJ; Koeter MW; van Wingen G; de Wit SJ; van den Heuvel OA; Veltman DJ; Ruhé HG; Schene AH
    JAMA Psychiatry; 2015 Jul; 72(7):687-96. PubMed ID: 25945779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics.
    Matosin N; Fernandez-Enright F; Frank E; Deng C; Wong J; Huang XF; Newell KA
    J Psychiatry Neurosci; 2014 Nov; 39(6):407-16. PubMed ID: 24949866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Role of mGluR5 in Cognitive Processes in Posttraumatic Stress Disorder and Major Depression.
    Esterlis I; DeBonee S; Cool R; Holmes S; Baldassari SR; Maruff P; Pietrzak RH; Davis MT
    Chronic Stress (Thousand Oaks); 2022; 6():24705470221105804. PubMed ID: 35958037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo metabotropic glutamate receptor 5 availability-associated functional connectivity alterations in drug-naïve young adults with major depression.
    Kim JH; Joo YH; Son YD; Kim JH; Kim YK; Kim HK; Lee SY; Ido T
    Eur Neuropsychopharmacol; 2019 Dec; 29(2):278-290. PubMed ID: 30553696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine-induced reduction in mGluR5 availability is associated with an antidepressant response: an [
    Esterlis I; DellaGioia N; Pietrzak RH; Matuskey D; Nabulsi N; Abdallah CG; Yang J; Pittenger C; Sanacora G; Krystal JH; Parsey RV; Carson RE; DeLorenzo C
    Mol Psychiatry; 2018 Apr; 23(4):824-832. PubMed ID: 28397841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine Use and Metabotropic Glutamate Receptor 5 in Individuals With Major Depressive and Posttraumatic Stress Disorders.
    Baldassarri SR; Asch RH; Hillmer AT; Pietrzak RH; DellaGioia N; Esterlis I; Davis MT
    Chronic Stress (Thousand Oaks); 2023; 7():24705470231154842. PubMed ID: 36843572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Metabotropic Glutamate Receptor 5 Availability With Both [
    Glorie D; Verhaeghe J; Miranda A; De Lombaerde S; Stroobants S; Staelens S
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2022 Jun; 7(6):607-615. PubMed ID: 34856382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688.
    DeLorenzo C; Sovago J; Gardus J; Xu J; Yang J; Behrje R; Kumar JS; Devanand DP; Pelton GH; Mathis CA; Mason NS; Gomez-Mancilla B; Aizenstein H; Mann JJ; Parsey RV
    Transl Psychiatry; 2015 Dec; 5(12):e693. PubMed ID: 26645628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resting-state functional network connectivity in prefrontal regions differs between unmedicated patients with bipolar and major depressive disorders.
    He H; Yu Q; Du Y; Vergara V; Victor TA; Drevets WC; Savitz JB; Jiang T; Sui J; Calhoun VD
    J Affect Disord; 2016 Jan; 190():483-493. PubMed ID: 26551408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociable patterns of abnormal frontal cortical activation during anticipation of an uncertain reward or loss in bipolar versus major depression.
    Chase HW; Nusslock R; Almeida JR; Forbes EE; LaBarbara EJ; Phillips ML
    Bipolar Disord; 2013 Dec; 15(8):839-854. PubMed ID: 24148027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insula and amygdala resting-state functional connectivity differentiate bipolar from unipolar depression.
    Ambrosi E; Arciniegas DB; Madan A; Curtis KN; Patriquin MA; Jorge RE; Spalletta G; Fowler JC; Frueh BC; Salas R
    Acta Psychiatr Scand; 2017 Jul; 136(1):129-139. PubMed ID: 28369737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.